ArticleFrontiers in immunology2024
A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine.
Xingxing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleFrontiers in immunology2024
Xingxing Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.